Bionano Genomics, Inc. — Form S-1
Filed October 27, 2026 · analyzed by the Registration Agent
S-1
— Neutral
significance 28/100
What the filing says
Bionano Genomics filed Form S-1 to register 1,332,632 shares of common stock issuable upon exercise of outstanding warrants: 661,377 shares at $15.12/share (2025 Purchase Warrants); 164,684 at $18.23/share (Series C); 145,560 at $61.20/share (2024 Purchase); 361,011 at $191.13/share (2023 Purchase). If exercised in full, company estimates ~$90M gross proceeds. Stock price: $1.16/share on Oct 26, 2026. Company is a smaller reporting company with going-concern risk noted by auditors.
Why this rating
Registration of existing warrants is routine administrative compliance. While ~$90M potential proceeds (7.4x current market cap) appears large, warrant exercise is uncertain/discretionary by holders. Going-concern disclosure is serious but not new. No material business change.
See more from October 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.